Skip to main content
. 2023 Sep 5;101(10):442–451. doi: 10.1212/WNL.0000000000207278

Figure. Overview of Methods for Standardizing MG Outcome Measures.

Figure

1Refer to eAppendix 1 (links.lww.com/WNL/C754) for list of attendees. 2Groups notified of public commentary: AANEM Connect, AAN Synapse, Alexion, Argenx, Biosensics, Cabaletta Bio, Clinical and Translational Science Award sites, Conquer MG, Horizon Therapeutics, Janssen, MGNet clinical sites, Muscular Dystrophy Association, Muscle Study Group, Myasthenia Gravis Foundation of America (posted on website), Rare Disease Clinical Research Networks (including NIH staff), Rick's Real Neuromuscular Friends, Signant, and UCB Pharma. 3Next steps of process, currently pending. AAN = American Academy of Neurology; AANEM = American Association of Neuromuscular & Electrodiagnostic Medicine; MG = myasthenia gravis.